Prof. Roger Philip Ekins

• 
  ww.healthtech.com/2002/mar/index.htm - [Cached Version]
  Published on: 1/1/2002    Last Visited: 3/1/2007  

  Prof. Roger Philip Ekins, University College London
  ...
  Prof. Roger Philip Ekins, Emeritus Professor and Head of Department, Division of Molecular Endocrinology, University College London

• 
  www.chidb.com/2002/mar/index.htm - [Cached Version]
  Published on: 1/1/2002    Last Visited: 10/8/2006  

  Prof. Roger Philip Ekins, University College London
  ...
  Prof. Roger Philip Ekins, Emeritus Professor and Head of Department, Division of Molecular Endocrinology, University College London

• 
  www.informapharma.com/cod/oinfo_lower.asp?COMPANY=USC&P - [Cached Version]
  Published on: 8/15/2000    Last Visited: 12/12/2000  

  Professor Roger Ekins, formally Head, Department of Molecular Endocrinology, University College London Medical School, United Kingdom
  
  ...
  Keynote Address by Dr. Roger Ekins - a founding father of microtechnologyLate-Breaking Topic SessionOptional Pre-Conference SymposiumSpecial Focus on Emerging Technologies and Actual Case StudyData from Beta Tests, as well as Commercial ApplicationsThree Poster Awards for $ 350, $ 250 and $ 100 as well as Oral Poster PresentationsExtensive Networking Time

• 
  www.eurobiochips.com/cod/display_lower.asp?pid=UKCIT114 - [Cached Version]
  Published on: 6/3/2000    Last Visited: 11/13/2000  

  Prof Roger Ekins, Director, Department of Molecular Endocrinology, University College London, UK
  
  09.40Using protein display chips for discovery and assay development in the drug discovery process.

• 
  Global Biotech 2002 Speakers - [Cached Version]
  Published on: 4/9/2006    Last Visited: 6/30/2008  

  Prof. Roger Ekins MA, PhD, Dsc, FRS, Head of Department, Molecular EndocrinologyUCL Medical School, UCL
  
  Professor Ekins is internationally recognised as the independent co-originator (with Drs Berson and Yalow) of radioimmunoassay (RIA) and related microanalytical techniques.Widely used to assay hormones and many other biologically-important substances in medical research and diagnosis, introduction of these techniques made a revolutionary impact on medicine, creating the $10 billion immunodiagnostics industry.
  
  In the mid-1980s he conceived of and patented a new generation of ultrasensitive, miniaturised, assays for protein and DNA/RNA measurement based on the use of "microarrays", this leading, in 1991, to his collaboration with Boehringer Mannheim in the technology's further development.Though outstandingly successful, the "Microspot®" project was (for legal reasons unrelated to the project's success or the technology's commercial prospects) halted in 1998 by Hoffmann-la Roche following its purchase of BM.Meanwhile international interest in microarray technology has exploded, being predicted by US analysts to form the basis of a $40 billion industry within the next decade.
  
  Professor Ekins has received many premier awards in recognition of his work in clinical chemistry, nuclear medicine, and endocrinology, including the IFCC's Distinguished Clinical Chemist Award, the von Hevesy Foundation's Georg von Hevesy Gold Medal, the British Nuclear Medicine Society's Veall medal, the Society for Endocrinology's Dale Medal, and, most recently, the AACC's inaugural Edwin F Ullman Award.
  ...
  Prof. Roger Ekins

• 
  Global Biotech 2002 – Workshops - [Cached Version]
  Published on: 4/9/2006    Last Visited: 6/30/2008  

  Chair: Roger Ekins, UCL Medical School

• 
  Professor Roger Ekins receives lifetime achievement... - [Cached Version]
  Published on: 12/11/2006    Last Visited: 12/25/2007  

  Professor Roger Ekins receives lifetime achievement award
  
  Professor Roger Ekins receives lifetime achievement award
  
  11 December 2006
  
  Professor EkinsProfessor Roger Ekins, FRS, past Head of UCL Molecular Endocrinology, has been presented with the Department of Health's Lifetime Achievement Award.
  
  This is the first such award to have been made by the DoH.Professor Ekins is internationally recognized as the independent co-originator of radioimmunoassay and related ‘ligand assay' methods.His development of these methods arose as a by product of his interests in endocrinology; in particular, his proposed existence of mechanisms that underlie crucial (but previously unsuspected) effects exerted by maternal hormones on the early development of the fetal brain.
  
  His first publication in the ligand field was in 1960, relating to the assay of serum thyroid hormones (a lack of which is often associated with goitre (swelling of the thyroid gland), but which are also implicated in various forms of cretinism).He has received many national and international awards for his work in the ligand assay field.Such assays are used worldwide for diagnostic purposes in almost every branch of medicine, ranging from routine diagnostic tests for thyroid function in all newborn infants to tests for viral diseases such as AIDS.
  
  These make up half of all diagnostic tests used by chemical pathologists and are the mainstay of a $10 billion dollar immunodiagnostics industry.In 1973, Professor Ekins launched (together with Professor J Landon of St Bart's) the Supra-regional (hormone) Assay Service, his lab being one of the seven university-based research laboratories funded by the DHSS to offer specialist testing in this area to doctors and hospitals throughout the UK (before commercial assay kits and instruments became available).
  
  In the mid-1980s, he conceived of a revolutionary ‘multianalyte' assay methodology (now referred to microarray or biochip-based assay technology) that is now transforming research in the fields of DNA and RNA analysis, immunoassay, genomics and proteomics, and estimated by market analysts to reach $40 billion p.a. in the next few years.This miniaturised technology permits the simultaneous, ultra-sensitive, measurement of thousands of different substances of biological importance (such as hormones, proteins, viruses, genes) in a single drop of blood.The technology has opened the door to the next revolution in diagnostics and to the widely predicted era of personalised medicine and targeted treatments.
  
  Image: Professor Ekins receiving his Lifetime Achievement Award from (left) DH Chief Scientific Officer, Sue Hill, and (right) Secretary of State for Health, the Rt Hon Patricia Hewitt MP

• 
  SNPs and Chips in Molecular Diagnostics - 15th Annual... - [Cached Version]
  Published on: 5/26/2000    Last Visited: 3/17/2001  

  Roger Ekins , D.ScDepartment of Molecular EndocrinologyUniversity College of London Medical SchoolLondon , UK
  
  12 : 00 – 1 : 30 Lunch , Exhibits and Posters
  
  Session : SNP Applications

• 
  Speculation heats up ahead of Nobel science prizes - [Cached Version]
  Published on: 1/3/2003    Last Visited: 10/3/2003  

  Oxford's Ed Southern, Roger Ekins of London Medical School and Steve Fodor of biotech firm Affymetrix, have developed ways of linking human DNA sequence to specific functions.

• 
  The Royal Society - News and Media - Media Releases - [Cached Version]
  Published on: 5/14/2001    Last Visited: 6/30/2004  

  Professor Roger Philip Ekins Emeritus Professor and Head of Department, Division of Molecular Endocrinology, University College London.Roger Ekins devised a general micro-analytical approach for analysing biologically important substances and established theoretical guidelines for the design of these methods.He later developed highly sensitive micro-arrays and devised immunological methods for estimating plasma free hormone concentrations.

Page:  1 2